Moldova latest patents query
The latest invention patents collect the data information of Moldova invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria
PendingMDE20250955A1
Owner:TRAVERE THERAPEUTICS SWITZERLAND GMBH +1
Method and system for protecting a user of one or more social networks or video games against risks of cyberbullying
PendingMDE20260188A1
Owner:SAFEBEAR
Access panel comprising a travel-stop bracket for the panel door
PendingMDE20260679A1
Owner:AKIFIX SPA
RNA-guided nucleases and active fragments and variants thereof and methods of use
PendingMDE20260431A1
Owner:LIFEEDIT THERAPEUTICS INC
Anchoring member for a facing panel for stabilised earth structures
PendingMDE20260132A1
Owner:OFFICINE MACCAFERRI SPA
Methods of characterizing and purifying VEGF receptor fusion protein
PendingMDE20260697A1
Owner:REGENERON PHARMACEUTICALS INC
Solid forms of modulators of cystic fibrosis transmembrane conductance regulator
PendingMDE20260621A1
Owner:VERTEX PHARMACEUTICALS INC
Adeno-associated virus vector encoding connexin 26 and uses thereof
PendingMDE20260121A1
Owner:SENSORION +1
Monoclonal antibody or antigen-binding fragment thereof that specifically binds to AXL, and use thereof
PendingMDE20260315A1
Owner:JOINT CO BIOCAD
Pharmaceutical compositions containing doravirine and islatravir
PendingMDE20260652A1
Owner:MERCK SHARP & DOHME LLC
Flame arrestor and flameless blast pressure relief device, in particular dust explosion pressure relief
PendingMDE20260094A1
Owner:REMBE GMBH SAFETY CONTROL
Compositions and methods for the treatment of Huntington's disease by editing the mutant huntingtin gene
PendingMDE20260156A1
Owner:LIFEEDIT THERAPEUTICS INC
Antibodies capable of binding to OX40, variants thereof and uses thereof
PendingMDE20260231A1
Owner:GENMAB AS +1
Methods and systems of controlling bidirectional operation of an electrowinning plant
PendingMDE20260379A1
Owner:FORM ENERGY INC
Use of Actinidia deliciosa and Olea europea plants bioengineered to over-express the osmotin plant protein and their derivates effectively lowers plasma glucose levels in type 2 diabetes mellitus patients and activates glycosuria
PendingMDE20260244A1
Owner:RUGGIERO BRUNO
Methods for the preparation and dose regimens for use of SSTR4 agonists and salts thereof
PendingMDE20260072A1
Owner:ELI LILLY & CO
Gastro-resistant coated pellet containing sodium bicarbonate, production thereof, pharmaceutical preparation and food supplement containing thereof, and their use
PendingMDE20260292A1
Owner:NUTRIGEN BIOSCIENCES GMBH
Dosage regimens for the treatment of autoimmune and inflammatory diseases using LY3871801
PendingMDE20260343A1
Owner:ELI LILLY & CO +1
Solid oral pharmaceutical compositions including alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor
PendingMDE20250944A1
Owner:MYLAN PHARMA INC
Compounds and methods for reducing TUBB4A expression
PendingMDE20260461A1
Owner:IONIS PHARMACEUTICALS INC
iRhom2 inhibitors and uses thereof
PendingMDE20260147A1
Owner:NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED & CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY US +1
Tropism-modified recombinant viral particles and uses thereof for the targeted introduction of genetic material into human cells
PendingMDE20260225A1
Owner:REGENERON PHARMACEUTICALS INC
Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof
PendingMDE20260249A1
Owner:INSILICO MEDICINE IP LTD
Methods of treatment using an anti-Aβ protofibril antibody
PendingMDE20260312A1
Owner:EISAI R&D MANAGEMENT CO LTD
Methods of treating epilepsy and related disorders with potent and selective potassium channel activators
PendingMDE20260574A1
Owner:BIOHAVEN THERAPEUTICS LTD
Salts, cocrystals, pharmaceutical compositions thereof, and methods of treatment involving the same
PendingMDE20260425A1
Owner:LES LAB SERVIER SA
Methods of treating cancer with a lymphotoxin beta receptor agonist
PendingMDE20260135A1
Owner:REGENERON PHARMACEUTICALS INC
Process and intermediates for the preparation of a P2X3 inhibitor
PendingMDE20260261A1
Owner:CHIESI FARMACEUTICI SPA
Combination of antibody-drug conjugate and anti-PD-1 / TIM-3 bispecific binding protein
PendingMDE20260694A1
Owner:ASTRAZENECA UK LTD +1
Compounds and methods for treating bacterial infections
PendingMDE20260589A1
Owner:ENTASIS THERAPEUTICS INC
Novel polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same
PendingMDE20260704A1
Owner:GENERATION BIO CO
Crystalline forms of 3-(5,7-difluoro-4-oxo-1,4-dihydroquinolin-2-yl)-4-(methylsulfonyl)benzonitrile
PendingMDE20260189A1
Owner:FLARE THERAPEUTICS INC
Topical skin formulations of a pharmaceutically acceptable salt of ruxolitinib
PendingMDE20260335A1
Owner:INCYTE CORP
Methods and compositions for treating CTNNB1-associated disorders
PendingMDE20260446A1
Owner:ALNYLAM PHARMACEUTICALS INC
Combination therapy using a KRAS G12D inhibitor and PD-1 inhibitor or PD-L1 inhibitor
PendingMDE20260646A1
Owner:INCYTE CORP
Vertebral nail: spine segmental fixation in compromised bone
PendingMDE20260459A1
Owner:KONDRASHOV DIMITRIY G +1
Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor
PendingMDE20260674A1
Owner:GENERATION BIO CO
The method of obtaining plates with aluminium (III) oxide nanolayers and the application of plated with aluminium (III) oxide nanolayers
PendingMDE20260080A1
Owner:UNIV MIKOLAJA KOPERNIKA
Pyrimidin-2-ylamino-1H-pyrazols as LRRK2 inhibitors for use in the treatment of neurodegenerative disorders
PendingMDE20260629A1
Owner:DENALI THERAPEUTICS INC
Production of fuels from hydroprocessed esters and fatty acids, low carbon hydrogen, and carbon dioxide in an integrated HEFA and eFuels plant
PendingMDE20260104A1
Owner:INFINIUM TECHNOLOGY LLC
Coupling device, valve system and method for operating a valve system
PendingMDE20260066A1
Owner:AKRAPOVIC D D
Stealth lipid nanoparticle compositions for cell targeting
PendingMDE20260702A1
Owner:GENERATION BIO CO
Method of treating ulcerative colitis with a combination of antibodies to IL-23 and TNF alpha
PendingMDE20260201A1
Owner:JANSSEN BIOTECH INC
Anti-MET antibodies, antibody-drug conjugates, compositions and uses thereof
PendingMDE20260248A1
Owner:LES LAB SERVIER SA
Methods of treating metastatic castration-resistant prostate cancer with bispecific anti-PSMA x anti-CD28 antibodies
PendingMDE20260450A1
Owner:REGENERON PHARMACEUTICALS INC
Polypeptide and derivative thereof, composition, and use thereof
PendingMDE20250947A1
Owner:HANG ZHOU SCIWIND BIOSCIENCES CO LTD +1
Potent transthyretin (TTR) stabilization in TTR amyloidosis patients receiving acoramidis
PendingMDE20260054A1
Owner:EIDOS THERAPEUTICS INC
Strip-shaped electrode for an electrochemical energy storage element
UndeterminedMDE20250294A1
Owner:DR ING H C F PORSCHE AG
2-(5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-5-nitrosopyrimidin-4,6-diamine or a salt thereof, method for the preparation thereof, and use thereof in the synthesis of vericiguat
UndeterminedMDE20250227A1
Owner:MOEHS IBERICA
Myeloid-derived growth factor for use in treating cardiogenic shock
UndeterminedMDE20250235A1
Owner:BOEHRINGER INGELHEIM INT GMBH
Methods for reducing infusion-related reactions in patients treated with EGFR / MET bispecific antibodies
UndeterminedMDE20241116A1
Owner:JANSSEN BIOTECH INC
T-type calcium channel modulators comprising a diazaspiroheptane core and methods of use thereof
UndeterminedMDE20250149A1
Owner:PRAXIS PRECISION MEDICINES INC
Formulations comprising heparan sulfate for the treatment and prevention of viral infections caused by Orthocoronaviridae
UndeterminedMDE20250462A1
Owner:ZONA SWISS SA
Methods of weight loss and preserving skeletal muscle mass
UndeterminedMDE20241123A1
Owner:RIVUS PHARMACEUTICALS INC
Pharmaceutical solutions of anti-N3pGlu A beta antibodies and uses thereof
UndeterminedMDE20250428A1
Owner:ELI LILLY & CO
Compositions and methods for inhibiting SNCA expression
UndeterminedMDE20250253A1
Owner:DICERNA PHARMACEUTICALS INC
Plant- or fungi based particles loaded with protein
UndeterminedMDE20250248A1
Owner:KONINK COOPERATIE COSUN U A
FimH mutant, compositions therewith and use thereof
UndeterminedMDE20250597A1
Owner:JANSSEN PHARMACEUTICALS INC
Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)
UndeterminedMDE20250015A1
Owner:AMGEN INC
Composition comprising N-acetylcysteine, vitamin D and preferably glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof
UndeterminedMDE20250177A1
Owner:URIACH ITALY SRL
ILT3 and CD3 binding agents and methods of use thereof
UndeterminedMDE20250123A1
Owner:NGM BIOPHARMACEUTICALS INC
Anti-BCMA CAR to target immune-related disorders, compositions and method thereof
UndeterminedMDE20241118A1
Owner:HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD +1
High concentration VEGF receptor fusion protein containing formulations
UndeterminedMDE20250237A1
Owner:REGENERON PHARMACEUTICALS INC
Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations
UndeterminedMDE20250046A1
Owner:AGIOS PHARMACEUTICALS INC
Genetically engineered mice models for multiple myeloma
UndeterminedMDE20250436A1
Owner:FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
T-type calcium channel modulators comprising a piperazine or 1,4-diazepane core and methods of use thereof
UndeterminedMDE20250150A1
Owner:PRAXIS PRECISION MEDICINES INC
Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor
UndeterminedMDE20250581A1
Owner:CHIESI FARMACEUTICI SPA
Safe and effective method of treating ulcerative colitis with anti-IL12 / IL23 antibody
UndeterminedMDE20250493A1
Owner:JANSSEN BIOTECH INC
Heteroarenes, pharmaceutical compositions containing the same, and methods of using the same
UndeterminedMDE20250280A1
Owner:REPARE THERAPEUTICS INC
Multispecific binding proteins that bind Dectin-1 and CD20 and methods of use thereof
UndeterminedMDE20250160A1
Owner:DREN BIO MANAGEMENT INC
A daytime radiative cooling cementitious composite (DRCCC)
PendingMDE20250738A1
Owner:CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) ES +7
Methods of treating chronic inflammatory demyelinating polyneuropathy using anti-FcRn antibodies
UndeterminedMDE20250553A1
Owner:IMVT CORP
Muscle targeting complexes and formulations for treating myotonic dystrophy
UndeterminedMDE20250182A1
Owner:DYNE THERAPEUTICS INC
New anti-SIRPa antibodies and their therapeutic applications
UndeterminedMDE20250545A1
Owner:OSE IMMUNOTHERAPEUTICS SA
[((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester for treatment of chronic cough
UndeterminedMDE20250003A1
Owner:AXALBION SA
Methods for treating brain glucose hypometabolism
UndeterminedMDE20250119A1
Owner:DENALI THERAPEUTICS INC
Medical device for disinfecting a volume of a hospital indoor environment and method for said disinfection
UndeterminedMDE20250090A1
Owner:TERRA VENTURES SRL
7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy
UndeterminedMDE20250224A1
Owner:ONCOCEUTICS INC
Amylin receptor (hAMY3R) agonists with improved chemical stability
UndeterminedMDE20250370A1
Owner:GUBRA APS
Compositions for maintaining lentiviral vector and uses thereof
UndeterminedMDE20250306A1
Owner:REGENERON PHARMACEUTICALS INC
Methods for the preparation of 5-chloro-2-((ethoxycarbonyl)amino)-3-methylbenzoic acid
UndeterminedMDE20250173A1
Owner:FMC CORP +1
Industrial process for the preparation of hexanoic acid, 6(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]3,5-dihydroxycyclopentyl]-1-(2-phenyl ethyl)-2-propen-1-yl ester and high pure product
UndeterminedMDE20250460A1
Owner:NICOX SA
5-[7-(3,4-dihydro-1h-isoquinoline-2-carbonyl)-1,2,3,4 tetrahydroisoquinolin-6-y l]-1h-pyrrole-3-carboxamide derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents
UndeterminedMDE20250020A1
Owner:LES LAB SERVIER SA +1
Carboxy derivatives with antiinflammatory properties
UndeterminedMDE20250658A1
Owner:SITRYX THERAPEUTICS LTD
Materials and methods for treatment of hemoglobinopathies
UndeterminedMDE20250475A1
Owner:VERTEX PHARMACEUTICALS INC
Anti-cd38 antibodies for treatment of light chain amyloidosis and other cd38-positive hematological malignancies
UndeterminedMDE20250399A1
Owner:JANSSEN BIOTECH INC +1
Multispecific antibodies having specificity for TNFα and IL-17A, antibodies targeting IL-17A, and methods of use thereof
UndeterminedMDE20250603A1
Owner:NUMAB THERAPEUTICS AG
Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof
UndeterminedMDE20250386A1
Owner:VIROMISSILE INC
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
UndeterminedMDE20250390A1
Owner:DYNE THERAPEUTICS INC
Means and methods for high-throughput glycoprofiling of proteins
UndeterminedMDE20250166A1
Owner:GLYCANOSTICS SRO
Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies
UndeterminedMDE20250477A1
Owner:REGENERON PHARMACEUTICALS INC
Tension spring for holding down a track body element
UndeterminedMDE20250530A1
Owner:VOESTALPINE TURNOUT TECH ZELTWEG GMBH +1
Tricyclic quinolone BCL6 bifunctional degraders
UndeterminedMDE20250328A1
Owner:TREELINE BIOSCIENCES INC